We're proud to share that the @US_FDA has granted accelerated approval for our therapy for advanced melanoma. Learn more: https://lnkd.in/etxeMZUK
Iovance Biotherapeutics, Inc.
Biotechnologisch onderzoek
San Carlos, California 24.001 volgers
Iovance is a patient-centric, collaborative organization that is driven to change the way cancer is treated.
Over ons
Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer. We are adding to our talented team as we execute our commercial launch, advance our research and development efforts, and build our internal manufacturing capabilities. Iovance is headquartered in the San Francisco Bay Area. Our Iovance Cell Therapy Center (iCTC), a state-of-the-art manufacturing facility, is located in Philadelphia. We also have a research site in Tampa, Florida. Any information expressed by Iovance is subject to the risk factors and information on forward-looking statements contained in its filings with the Securities and Exchange Commission and available here: https://ir.iovance.com/sec-filings
- Website
-
http://www.iovance.com/
Externe link voor Iovance Biotherapeutics, Inc.
- Branche
- Biotechnologisch onderzoek
- Bedrijfsgrootte
- 501 - 1.000 medewerkers
- Hoofdkantoor
- San Carlos, California
- Type
- Naamloze vennootschap
- Opgericht
- 2007
- Specialismen
- Immuno Oncology, Autologous Cell Therapy, Tumor Infiltrating Lymphocytes (TIL), Novel Cancer Immunotherapies en cell therapy
Locaties
Medewerkers van Iovance Biotherapeutics, Inc.
Updates
-
Iovance Biotherapeutics, Inc. heeft dit gerepost
On #RareCancerDay, we would like to raise awareness of some of the rarer melanoma subtypes including ocular, mucosal, pediatric and acral lentiginous melanoma. Not as common as cutaneous (skin) melanoma, these subtypes of melanoma are rarely caused due to sun exposure and may not benefit from drugs that are effective for cutaneous melanoma. More research and awareness are desperately needed for these rarer melanoma subtypes and as such the MRF has sponsored several awareness campaigns, meetings and grants in these areas. #EyeGetDilated #OutoftheShadows #SpotTheDog #Acral
-
Join us tomorrow at our iCTC Night Shift Job Fair to learn about opportunities at Iovance. Visit our website for a listing of open roles: https://lnkd.in/gDy--h3i #phillyjobs #philadelphiajobs #phillycareers #philadelphiacareers
-
Today, Howard Johnson, Chief Business Officer, and Brian Gastman, EVP, Medical Affairs, will participate in a Fireside Chat at the Wells Fargo Healthcare Conference in Boston at 3:45 pm EDT. To listen to the live webcast or the replay, register here: https://lnkd.in/d3asmiGj
-
Today Iovance reported second quarter and first half 2024 financial results and corporate updates. We will host an audio webcast at 4:30 pm ET, join live or listen to the replay: https://lnkd.in/e6S3bW7n
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024 | IOVANCE Biotherapeutics, Inc.
ir.iovance.com
-
Thank you Chris Rollins for inspiring a culture of #RippleEffectLeadership. Empathy and single acts of kindness create a powerful #RippleEffect on our daily work and the pursuit of our mission at Iovance!”
The Ripple Effect Leader™ 🌊 | Purpose-Driven Keynote Speaker | 2024 TBBJ Business of Pride Honoree | Building High Trust in a Low-Trust World
Slowing down isn’t about doing less; it’s about focusing on what truly matters. Taking time to share stories, to genuinely see and connect with one another, to listen and build empathy, understanding, and trust... These are some of the foundations of strong teams, strong cultures, and #RippleEffectLeadership. And when you're innovating, developing and delivering life-saving individualized cancer therapies like at Iovance Biotherapeutics, Inc., having a high level of trust is crucial for effective teamwork, communication and collaboration. I'm so grateful that Alyssa Sy, Ashley Gallego and Elizabeth Gonzalez saw me speak in Tampa back in March and believed in the power of #TheRippleEffect. We just wrapped up an amazing day at their site at The Navy Yard in Philadelphia with a private tour of their facility, a talk for their employees and a two-hour workshop with a group of their leaders. There were tears, hugs, laughs, and 10 lbs of pebbles that I somehow managed to get through TSA 😂 Thank you for the incredible hospitality and for trusting in me! Big thanks to my amazing partners at SpeakInc for the flawless execution teaming up on this event.
-
Join us Monday, June 24 for our job fair to learn more about opportunities at Iovance Cell Therapy Center in the Navy Yard Philadelphia! Open roles: https://lnkd.in/gDy--h3i #philadelphiajobs #phillyjobs #biotechjobs
We're hiring! To learn more about open positions at the Iovance Cell Therapy Center in the Philadelphia Navy Yard, attend our job fair on Monday, June 24. View current open positions here: https://lnkd.in/gDy--h3i
Deze content is hier niet beschikbaar
Open deze content en meer in de LinkedIn-app
-
Interested in learning more about career opportunities at Iovance in Philadelphia? Please join us on June 24 for our Iovance Cell Therapy Center Job Fair to learn more and meet members of our team. #philadelphiajobs #phillyjobs #philadelphiacareers #phillycareers #celltherapycareers
We're hiring! To learn more about open positions at the Iovance Cell Therapy Center in the Philadelphia Navy Yard, attend our job fair on Monday, June 24. View current open positions here: https://lnkd.in/gDy--h3i
Deze content is hier niet beschikbaar
Open deze content en meer in de LinkedIn-app
-
Iovance Biotherapeutics, Inc. heeft dit gerepost
📢 Tomorrow (June 4) is the last day to apply for The Wistar Institute's award-winning Biomedical Technician Training Program! Those with a high school diploma or equivalent and an interest in the life sciences are encouraged to apply. Upon successful completion of the training program, applicants will have an opportunity to interview for open positions with Iovance Biotherapeutics, Inc. or Integral Molecular with roles starting at $21/hour. More information below ⬇
The Wistar Institute’s award-winning Biomedical Technician Training (BTT) Program has begun another recruitment effort for Philadelphians looking to participate in our region’s thriving life science economy. “In this fifth cohort of our BTT Program with the West Philadelphia Skills Initiative , we are excited to train Philadelphia residents for job opportunities with Integral Molecular and Iovance Biotherapeutics, Inc. - two employers fueling the life science sector here in Philadelphia,” said Dr. Kristy Shuda McGuire, Dean of Biomedical Studies in the Hubert J.P. Schoemaker Education and Training Center at The Wistar Institute. Read our story about this collaboration between Wistar, WPSI, Integral Molecular, Iovance Biotherapeutics, PIDC, and The Chamber of Commerce for Greater Philadelphia here: https://bit.ly/4bPeawh #training #phillylifesciences #opportunity #philly
Award-Winning Biotech Program Begins Another Recruitment to Connect Philadelphians with Quality Jobs in the Region’s Rapidly Growing Life Science Sector
https://www.wistar.org
-
Iovance Biotherapeutics, Inc. heeft dit gerepost
The Wistar Institute’s award-winning Biomedical Technician Training (BTT) Program has begun another recruitment effort for Philadelphians looking to participate in our region’s thriving life science economy. “In this fifth cohort of our BTT Program with the West Philadelphia Skills Initiative , we are excited to train Philadelphia residents for job opportunities with Integral Molecular and Iovance Biotherapeutics, Inc. - two employers fueling the life science sector here in Philadelphia,” said Dr. Kristy Shuda McGuire, Dean of Biomedical Studies in the Hubert J.P. Schoemaker Education and Training Center at The Wistar Institute. Read our story about this collaboration between Wistar, WPSI, Integral Molecular, Iovance Biotherapeutics, PIDC, and The Chamber of Commerce for Greater Philadelphia here: https://bit.ly/4bPeawh #training #phillylifesciences #opportunity #philly
Award-Winning Biotech Program Begins Another Recruitment to Connect Philadelphians with Quality Jobs in the Region’s Rapidly Growing Life Science Sector
https://www.wistar.org
Vergelijkbare pagina’s
Door vacatures bladeren
Financiering
Laatste ronde
Vermogen na beursgangUS$ 211.000.000,00